American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2021, 9(7), 354-357
DOI: 10.12691/ajmcr-9-7-3
Open AccessCase Report

A Rare Case of Anti-NMDA Receptor Encephalitis Associated with an Ovarian Teratoma

Eiad Habib1, , Jay Patel2, 3, Connor Kerndt2, 3, Dan Summers2, 3 and TaLawnda Bragg2, 3

1Alfaisal University College of Medicine, Riyadh, Saudi Arabia 11533

2Department of Internal Medicine, Spectrum Health Butterworth Hospital, Grand Rapids, Michigan, USA 49503

3Michigan State University College of Human Medicine, Grand Rapids, Michigan, USA

Pub. Date: April 06, 2021

Cite this paper:
Eiad Habib, Jay Patel, Connor Kerndt, Dan Summers and TaLawnda Bragg. A Rare Case of Anti-NMDA Receptor Encephalitis Associated with an Ovarian Teratoma. American Journal of Medical Case Reports. 2021; 9(7):354-357. doi: 10.12691/ajmcr-9-7-3

Abstract

Anti-N-methyl-D-aspartate (NMDA)-receptor encephalitis is a syndrome of psychiatric symptoms and neurologic sequelae that is commonly associated with an ovarian teratoma. The antagonism of cerebral NMDA receptors disrupts normal brain activity causing acute onset psychological disturbances including mania, psychosis, or anxiety. Due to the rarity of the condition, diagnosis may be delayed as other common disorders such as primary psychiatric disorders or infectious encephalitis are ruled out. With rapid diagnosis and management, including resection of the tumor and immunotherapy, positive outcomes may be achieved. We present the case of a 25-year-old female with neuropsychiatric manifestations and an ovarian teratoma who was subsequently diagnosed with anti-NMDA-receptor encephalitis.

Keywords:
paraneoplastic anti-NMDA receptor encephalitis ovarian teratoma

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  K. Nokura, H. Yamamoto, Y. Okawara, H. Koga, H. Osawa, and K. Sakai, “Reversible limbic encephalitis caused by ovarian teratoma,” Acta Neurol. Scand., vol. 95, no. 6, pp. 367-373, 1997.
 
[2]  H. Okamura, N. Oomori, and Y. Uchitomi, “An acutely confused 15-year-old girl,” Lancet, vol. 350, no. 9076, p. 488, Aug. 1997.
 
[3]  R. Vitaliani, W. Mason, B. Ances, T. Zwerdling, Z. Jiang, and J. Dalmau, “Paraneoplastic encephalitis, psychiatric symptoms, and hypoventilation in ovarian teratoma,” Ann. Neurol., vol. 58, no. 4, pp. 594-604, 2005.
 
[4]  J. Dalmau et al., “Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies,” Lancet Neurol., vol. 7, no. 12, pp. 1091-1098, Dec. 2008.
 
[5]  A. P. Mann, E. Grebenciucova, and R. V. Lukas, “Anti-N-methyl-D-aspartate-receptor encephalitis: Diagnosis, optimal management, and challenges,” Therapeutics and Clinical Risk Management, vol. 10, no. 1. Dove Medical Press Ltd., pp. 517-524, 2014.
 
[6]  J. A. Braverman, C. Marcus, and R. Garg, “Anti-NMDA-receptor encephalitis: A neuropsychiatric syndrome associated with ovarian teratoma,” Gynecol. Oncol. Reports, vol. 14, pp. 1-3, Nov. 2015.
 
[7]  M. J. Titulaer et al., “Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: An observational cohort study,” Lancet Neurol., vol. 12, no. 2, pp. 157-165, Feb. 2013.
 
[8]  J. Dalmau et al., “Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma,” Ann. Neurol., vol. 61, no. 1, pp. 25-36, Jan. 2007.
 
[9]  J. Dalmau, E. Lancaster, E. Martinez-Hernandez, M. R. Rosenfeld, and R. Balice-Gordon, “Clinical experience and laboratory investigations in patients with anti-NMDAR encephalitis,” The Lancet Neurology, vol. 10, no. 1. Lancet Neurol, pp. 63-74, Jan-2011.
 
[10]  H. C. Chiu, Y. C. Su, S. C. Huang, H. L. Chiang, and P. S. Huang, “Anti-NMDAR encephalitis with ovarian teratomas: Review of the literature and two case reports,” Taiwan. J. Obstet. Gynecol., vol. 58, no. 3, pp. 313-317, May 2019.
 
[11]  M. S. Kayser and J. Dalmau, “Anti-NMDA Receptor Encephalitis in Psychiatry,” Curr. Psychiatry Rev., vol. 7, no. 3, pp. 189-193, Aug. 2011.
 
[12]  P. Acién, M. Acién, E. Ruiz-Maciá, and C. Martín-Estefanía, “Ovarian teratoma-associated anti-NMDAR encephalitis: a systematic review of reported cases,” Orphanet J. Rare Dis., vol. 9, no. 1, p. 157, Dec. 2014.
 
[13]  M. G. Ferreira, V. L. Alcalde, M. H. G. Sánchez, L. H. Hernández, and M. J. Doyague Sánchez, “Successful treatment of anti-NMDA receptor encephalitis with early teratoma removal and plasmapheresis: A case report,” Med. (United States), vol. 97, no. 31, Aug. 2018.
 
[14]  A. D. Mitra and A. Afifya, “Ovarian teratoma associated Anti N-methyl-D-aspartate receptor encephalitis: A difficult diagnosis with a favorable p¬rognosis.,” Autops. Case Reports, vol. 8, no. 2, 2018.
 
[15]  A. Tumbi, A. Gilani, J. R. Scarff, G. Kaur, and S. Lippmann, “Anti-N-methyl-D encephalitis.,” Innov. Clin. Neurosci., vol. 8, no. 9, pp. 24-5, 2011.